Correlation Between Valneva SE and CERo Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Valneva SE and CERo Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Valneva SE and CERo Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Valneva SE ADR and CERo Therapeutics Holdings, you can compare the effects of market volatilities on Valneva SE and CERo Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Valneva SE with a short position of CERo Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Valneva SE and CERo Therapeutics.

Diversification Opportunities for Valneva SE and CERo Therapeutics

-0.63
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Valneva and CERo is -0.63. Overlapping area represents the amount of risk that can be diversified away by holding Valneva SE ADR and CERo Therapeutics Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on CERo Therapeutics and Valneva SE is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Valneva SE ADR are associated (or correlated) with CERo Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of CERo Therapeutics has no effect on the direction of Valneva SE i.e., Valneva SE and CERo Therapeutics go up and down completely randomly.

Pair Corralation between Valneva SE and CERo Therapeutics

Given the investment horizon of 90 days Valneva SE ADR is expected to generate 0.19 times more return on investment than CERo Therapeutics. However, Valneva SE ADR is 5.22 times less risky than CERo Therapeutics. It trades about 0.08 of its potential returns per unit of risk. CERo Therapeutics Holdings is currently generating about -0.01 per unit of risk. If you would invest  396.00  in Valneva SE ADR on September 28, 2024 and sell it today you would earn a total of  23.70  from holding Valneva SE ADR or generate 5.98% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Valneva SE ADR  vs.  CERo Therapeutics Holdings

 Performance 
       Timeline  
Valneva SE ADR 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Valneva SE ADR has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's essential indicators remain very healthy which may send shares a bit higher in January 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.
CERo Therapeutics 

Risk-Adjusted Performance

13 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in CERo Therapeutics Holdings are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. In spite of fairly conflicting basic indicators, CERo Therapeutics showed solid returns over the last few months and may actually be approaching a breakup point.

Valneva SE and CERo Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Valneva SE and CERo Therapeutics

The main advantage of trading using opposite Valneva SE and CERo Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Valneva SE position performs unexpectedly, CERo Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CERo Therapeutics will offset losses from the drop in CERo Therapeutics' long position.
The idea behind Valneva SE ADR and CERo Therapeutics Holdings pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.

Other Complementary Tools

Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Insider Screener
Find insiders across different sectors to evaluate their impact on performance